| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Oct 29, 2026 |
Absci Corp
ABSI
|
BUY |
$14.00
Est. +18%
|
$11.88 | $12.54 |
Pending
|
$10.48
-11.8%
|
| Oct 07, 2026 |
Rocket Pharmaceuticals Inc
RCKT
|
BUY |
$2.95
Est. +19%
|
$2.48 | $2.78 |
Pending
|
$2.61
+5.2%
|
| Sep 30, 2026 |
Dyne Therapeutics Inc
DYN
|
BUY |
$50.00
Est. +208%
|
$16.21 | $19.00 |
Pending
|
$18.54
+14.4%
|
| Sep 28, 2026 |
Xenon Pharmaceuticals Inc
XENE
|
BUY |
$90.00
Est. +144%
|
$36.94 | $39.92 |
Pending
|
$39.19
+6.1%
|
| Aug 31, 2026 |
Bar Harbor Bankshares Inc
BHB
|
BUY |
$48.00
Est. +22%
|
$39.40 | $42.57 |
Pending
|
$42.49
+7.8%
|
| Aug 14, 2026 |
Minerva Neurosciences Inc
NERV
|
BUY |
$10.00
Est. +155%
|
$3.92 | $5.63 |
Pending
|
$2.57
-34.4%
|
| Jun 11, 2026 |
Axsome Therapeutics Inc
AXSM
|
BUY |
$380.00
Est. +54%
|
$246.34 | $260.19 |
Pending
|
$137.00
-44.4%
|
| May 04, 2026 |
Axsome Therapeutics Inc
AXSM
|
BUY |
$275.00
Est. +21%
|
$227.92 | $260.19 |
Pending
|
$137.00
-39.9%
|
| Mar 16, 2026 |
Alto Neuroscience Inc.
ANRO
|
BUY |
$35.00
Est. +41%
|
$24.78 | $37.43 |
Target Met
|
$23.30
-6.0%
|
| Mar 09, 2026 |
Xenon Pharmaceuticals Inc
XENE
|
BUY |
$65.00
Est. +6%
|
$61.56 | $72.66 |
Target Met
|
$39.19
-36.3%
|
| Mar 09, 2026 |
Xenon Pharmaceuticals Inc
XENE
|
BUY |
$100.00
Est. +59%
|
$62.76 | $72.66 |
Pending
|
$39.19
-37.6%
|
| Mar 06, 2026 |
ATAI Life Sciences N.V.
ATAI
|
BUY |
$10.00
Est. +195%
|
$3.39 | $7.44 |
Pending
|
$7.35
+116.8%
|
| Mar 03, 2026 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$30.00
Est. +88%
|
$15.98 | $23.85 |
Pending
|
$18.99
+18.8%
|
| Mar 03, 2026 |
Moderna Inc
MRNA
|
SELL |
$37.00
Est. +26%
|
$49.83 | $43.68 (Low) |
Pending
|
$258.38
-418.5%
|
| Mar 02, 2026 |
Denali Therapeutics Inc
DNLI
|
BUY |
$40.00
Est. +90%
|
$21.00 | $27.30 |
Pending
|
$20.96
-0.2%
|
| Feb 12, 2026 |
BridgeBio Pharma Inc
BBIO
|
BUY |
$100.00
Est. +31%
|
$76.06 | $93.42 |
Pending
|
$77.89
+2.4%
|
| Feb 01, 2026 |
Helus Pharma Inc.
HELP
|
BUY |
$22.00
Est. +232%
|
$6.62 | $12.71 |
Pending
|
$8.68
+31.1%
|
| Dec 17, 2025 |
Vistagen Therapeutics Inc.
VTGN
|
BUY |
$0.90
Est. +5%
|
$0.86 | $0.97 |
Target Met
|
$0.19
-78.2%
|
| Nov 21, 2025 |
MapLight Therapeutics, Inc.
MPLT
|
BUY |
$32.00
Est. +141%
|
$13.29 | $40.43 |
Target Met
|
$6.71
-49.5%
|
| Oct 22, 2025 |
Avadel Pharmaceuticals plc
AVDL
|
BUY |
$20.00
Est. +8%
|
$18.55 | $23.57 |
Target Met
|
$21.64
+16.7%
|
| Oct 16, 2025 |
Praxis Precision Medicines Inc
PRAX
|
BUY |
$300.00
Est. +71%
|
$175.76 | $391.64 |
Target Met
|
$284.79
+62.0%
|
| Sep 25, 2025 |
Biogen Inc
BIIB
|
BUY |
$190.00
Est. +38%
|
$137.67 | $229.01 |
Target Met
|
$254.46
+84.8%
|
| Jul 18, 2025 |
Marcus Corp.
MCS
|
BUY |
$30.00
Est. +65%
|
$18.21 | $24.71 |
Miss
|
$28.06
+54.1%
|
| May 28, 2025 |
Rocket Pharmaceuticals Inc
RCKT
|
BUY |
$2.50
Est. +1%
|
$2.48 | $5.45 |
Target Met
|
$2.61
+5.2%
|
| May 20, 2025 |
ATAI Life Sciences N.V.
ATAI
|
BUY |
$5.00
Est. +144%
|
$2.05 | $6.73 |
Target Met
|
$7.35
+258.5%
|
| Oct 21, 2024 |
GE Vernova Inc.
GEV
|
SELL |
$165.00
Est. +40%
|
$274.85 | $252.38 (Low) |
Miss
|
$832.83
-203.0%
|
| Oct 21, 2024 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$165.00
Est. +30%
|
$127.08 | $138.69 |
Miss
|
$18.99
-85.1%
|
| Jul 02, 2024 |
Rapport Therapeutics Inc.
RAPP
|
BUY |
$35.00
Est. +38%
|
$25.44 | $29.74 |
Miss
|
$25.93
+1.9%
|
| May 28, 2024 |
Verona Pharma Plc - ADR
VRNA
|
BUY |
$38.00
Est. +204%
|
$12.50 | $76.89 |
Target Met
|
$106.91
+755.3%
|
| May 07, 2024 |
Intra-Cellular Therapies Inc
ITCI
|
BUY |
$105.00
Est. +50%
|
$70.08 | $131.98 |
Target Met
|
$131.87
+88.2%
|
| Oct 13, 2022 |
Relmada Therapeutics Inc
RLMD
|
BUY |
$8.00
Est. +23%
|
$6.48 | - | - |
$4.17
-35.6%
|
| Jul 22, 2022 |
Vistagen Therapeutics Inc.
VTGN
|
SELL |
$0.20
Est. +95%
|
$4.38 | - | - |
$0.19
+95.7%
|
| Jun 22, 2022 |
Athira Pharma Inc
ATHA
|
BUY |
$3.00
Est. +5%
|
$2.85 | $4.41 |
Target Met
|
$6.75
+136.8%
|
| Jun 22, 2022 |
LeonaBio, Inc.
LONA
|
BUY |
$3.00
Est. +5%
|
$2.85 | - | - |
$4.57
+60.2%
|